Pancreatic Cancer Research

ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed

Michael Tachezy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1706-2588; OpenAlex author ID A5037035901. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2011: 3 papers · 2012: 2 papers · 2013: none · 2014: 4 papers · 2015: 1 paper · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 15

  1. Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression. Co-author DOI 10.1186/s13046-021-01946-2↗
  2. Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-18-0120↗
  3. Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer. Co-author DOI 10.1080/15384047.2017.1281499↗
  4. Pancreatic cancer and liver metastases: state of the art. Co-author DOI 10.1007/s13304-016-0407-7↗
  5. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicent… Co-author DOI 10.1016/j.surg.2016.02.019↗
  6. Resection margin clearance in pancreatic cancer after implementation of the Leeds Pathology Protocol (LEEPP): clinically relevant or just academic? First author DOI 10.1007/s00268-014-2808-4↗
  7. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0716↗
  8. Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinom… Co-author DOI 10.1186/1471-2407-14-411↗
  9. Carcinoembryonic antigen-related cell adhesion molecules (CEACAM) 1, 5 and 6 as biomarkers in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0113023↗
  10. Serum EpCAM expression in pancreatic cancer. Co-author PMID 25202052↗
  11. Disseminated tumor cells in pancreatic cancer-an independent prognosticator of disease progression and survival. Co-author DOI 10.1002/ijc.26439↗
  12. ALCAM (CD166) expression and serum levels in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0039018↗
  13. Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma. First author DOI 10.1002/jso.21957↗
  14. Multivisceral resections in pancreatic cancer: identification of risk factors. Co-author DOI 10.1007/s00268-011-1263-8↗
  15. Bypass surgery versus intentionally incomplete resection in palliation of pancreatic cancer: is resection the lesser evil? Co-author DOI 10.1007/s11605-011-1469-y↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Florian Gebauer · 14 shared papers, 2011–2021 · strength 0.71
  2. Maximilian Bockhorn · 14 shared papers, 2011–2018 · strength 0.63
  3. Jakob Robert Izbicki · 13 shared papers, 2011–2021 · strength 0.60
  4. Daniel Wicklein · 3 shared papers, 2014–2021 · strength 0.20
  5. Udo Schumacher · 3 shared papers, 2014–2021 · strength 0.20
  6. Yogesh Kumar Vashist · 5 shared papers, 2011–2015 · strength 0.19
  7. Katharina E. Effenberger · 3 shared papers, 2011–2018 · strength 0.13
  8. Emre F. Yekebas · 3 shared papers, 2011–2015 · strength 0.12
  9. Achim Michael Aigner · 1 shared paper, 2021 · strength 0.11
  10. Marius Kemper · 1 shared paper, 2021 · strength 0.11
  11. Jacob Robert Izbicki · 1 shared paper, 2018 · strength 0.08
  12. Eugen Bellon · 1 shared paper, 2016 · strength 0.08
  13. Sujuan Yang · 1 shared paper, 2017 · strength 0.06
  14. Raghu Kalluri · 1 shared paper, 2017 · strength 0.06
  15. Sónia A. Melo · 1 shared paper, 2017 · strength 0.06
  16. Jussuf T. Kaifi · 2 shared papers, 2011 · strength 0.06
  17. Matthias Reeh · 2 shared papers, 2011–2012 · strength 0.06
  18. Christos Dervenis · 1 shared paper, 2016 · strength 0.05
  19. Giuseppe Malleo · 1 shared paper, 2016 · strength 0.05
  20. Mustapha Adham · 1 shared paper, 2016 · strength 0.05
  21. Christos Agalianos · 1 shared paper, 2016 · strength 0.05
  22. Laura Maggino · 1 shared paper, 2016 · strength 0.05
  23. Waldemar H. Uhl · 1 shared paper, 2016 · strength 0.05
  24. Julie Périnel · 1 shared paper, 2016 · strength 0.05
  25. Alessandro Zerbi · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.